Cell Cycle Progression Score as a Predictor of Progression of ccRCC

James A. Brown, MD, Professor of Urology, Professor of Biomedical Engineering, University of Iowa Carver College of Medicine, discusses an analysis of cell cycle progression scores in patients with clear cell renal cell carcinoma (ccRCC) to evaluate its prognostic value.

James A. Brown, MD, Professor of Urology, Professor of Biomedical Engineering, University of Iowa Carver College of Medicine, discusses an analysis of cell cycle progression scores in patients with clear cell renal cell carcinoma (ccRCC) to evaluate its prognostic value.

Clinical Pearls:

  • There are no cell cycle progression score tests, like Polaris, for patients with renal cell carcinoma
  • Renal cell carcinoma is the most lethal of all urologic malignancies
  • Having a similar test to Polaris would help physicians identify which patients with renal cell carcinoma will develop spread of disease